Langman, C. B. (2023). Long-term clinical benefits of delayed-release cysteamine bitartrate capsules in patients with nephropathic cystinosis (response to "A comparison of immediate release and delayed release cysteamine in 17 patients with nephropathic cystinosis"). Orphanet Journal of Rare Diseases, 18(1), 1-3. https://doi.org/10.1186/s13023-023-02724-3
Chicago Style (17th ed.) CitationLangman, Craig B. "Long-term Clinical Benefits of Delayed-release Cysteamine Bitartrate Capsules in Patients with Nephropathic Cystinosis (response to "A Comparison of Immediate Release and Delayed Release Cysteamine in 17 Patients with Nephropathic Cystinosis")." Orphanet Journal of Rare Diseases 18, no. 1 (2023): 1-3. https://doi.org/10.1186/s13023-023-02724-3.
MLA (8th ed.) CitationLangman, Craig B. "Long-term Clinical Benefits of Delayed-release Cysteamine Bitartrate Capsules in Patients with Nephropathic Cystinosis (response to "A Comparison of Immediate Release and Delayed Release Cysteamine in 17 Patients with Nephropathic Cystinosis")." Orphanet Journal of Rare Diseases, vol. 18, no. 1, 2023, pp. 1-3, https://doi.org/10.1186/s13023-023-02724-3.
Visit our Citation Styles guide for help on properly citing sources.